Orient EuroPharma Co., Ltd. (TPEX:4120)

Orient EuroPharma Revenue

Orient EuroPharma had revenue of 1.13B TWD in the quarter ending June 30, 2025, with 3.70% growth. This brings the company's revenue in the last twelve months to 4.48B, down -0.34% year-over-year. In the year 2024, Orient EuroPharma had annual revenue of 4.39B, down -4.37%.

• Revenue (ttm): 4.48B
• Revenue Growth: -0.34%
• P/S Ratio: 0.90
• Revenue / Employee: 13.23M
• Employees: 339
• Market Cap: 4.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.39B	-200.59M	-4.37%
Dec 31, 2023	4.59B	-138.56M	-2.93%
Dec 31, 2022	4.73B	-36.57M	-0.77%
Dec 31, 2021	4.77B	-616.63M	-11.45%
Dec 31, 2020	5.38B	-709.60M	-11.65%